Cargando…

Evaluating the protective efficacy of a trivalent vaccine containing Akabane virus, Aino virus and Chuzan virus against Schmallenberg virus infection

Schmallenberg virus (SBV), an arthropod borne pathogen, spread rapidly throughout the majority of Europe since 2011. It can cause a febrile disease, milk drop, diarrhea, and fetal malformation in ruminants. SBV, a member of the Simbu serogroup within the genus Orthobunyavirus, is closely related to...

Descripción completa

Detalles Bibliográficos
Autores principales: Hechinger, Silke, Wernike, Kerstin, Beer, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4028744/
https://www.ncbi.nlm.nih.gov/pubmed/24313924
http://dx.doi.org/10.1186/1297-9716-44-114
_version_ 1782317095276511232
author Hechinger, Silke
Wernike, Kerstin
Beer, Martin
author_facet Hechinger, Silke
Wernike, Kerstin
Beer, Martin
author_sort Hechinger, Silke
collection PubMed
description Schmallenberg virus (SBV), an arthropod borne pathogen, spread rapidly throughout the majority of Europe since 2011. It can cause a febrile disease, milk drop, diarrhea, and fetal malformation in ruminants. SBV, a member of the Simbu serogroup within the genus Orthobunyavirus, is closely related to Akabane virus (AKAV) and Aino virus (AINOV) among others. In the present study, 4 Holstein-Friesian calves were immunized twice four weeks apart with a multivalent, inactivated vaccine against AKAV and AINOV. Another 4 calves were kept as unvaccinated controls. All animals were clinically, serologically and virologically examined before and after challenge infection with SBV. AKAV- and AINOV-specific neutralizing antibodies were detected one week before challenge infection, while SBV-specific antibodies were detectable only thereafter. SBV genome was detected in all vaccinated animals and 3 out of 4 controls in serum samples taken after challenge infection. In conclusion, the investigated vaccine was not able to prevent an SBV-infection. Thus, vaccines for other related Simbu serogroup viruses can not substitute SBV-specific vaccines as an instrument for disease control.
format Online
Article
Text
id pubmed-4028744
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40287442014-05-22 Evaluating the protective efficacy of a trivalent vaccine containing Akabane virus, Aino virus and Chuzan virus against Schmallenberg virus infection Hechinger, Silke Wernike, Kerstin Beer, Martin Vet Res Research Schmallenberg virus (SBV), an arthropod borne pathogen, spread rapidly throughout the majority of Europe since 2011. It can cause a febrile disease, milk drop, diarrhea, and fetal malformation in ruminants. SBV, a member of the Simbu serogroup within the genus Orthobunyavirus, is closely related to Akabane virus (AKAV) and Aino virus (AINOV) among others. In the present study, 4 Holstein-Friesian calves were immunized twice four weeks apart with a multivalent, inactivated vaccine against AKAV and AINOV. Another 4 calves were kept as unvaccinated controls. All animals were clinically, serologically and virologically examined before and after challenge infection with SBV. AKAV- and AINOV-specific neutralizing antibodies were detected one week before challenge infection, while SBV-specific antibodies were detectable only thereafter. SBV genome was detected in all vaccinated animals and 3 out of 4 controls in serum samples taken after challenge infection. In conclusion, the investigated vaccine was not able to prevent an SBV-infection. Thus, vaccines for other related Simbu serogroup viruses can not substitute SBV-specific vaccines as an instrument for disease control. BioMed Central 2013 2013-12-05 /pmc/articles/PMC4028744/ /pubmed/24313924 http://dx.doi.org/10.1186/1297-9716-44-114 Text en Copyright © 2013 Hechinger et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Hechinger, Silke
Wernike, Kerstin
Beer, Martin
Evaluating the protective efficacy of a trivalent vaccine containing Akabane virus, Aino virus and Chuzan virus against Schmallenberg virus infection
title Evaluating the protective efficacy of a trivalent vaccine containing Akabane virus, Aino virus and Chuzan virus against Schmallenberg virus infection
title_full Evaluating the protective efficacy of a trivalent vaccine containing Akabane virus, Aino virus and Chuzan virus against Schmallenberg virus infection
title_fullStr Evaluating the protective efficacy of a trivalent vaccine containing Akabane virus, Aino virus and Chuzan virus against Schmallenberg virus infection
title_full_unstemmed Evaluating the protective efficacy of a trivalent vaccine containing Akabane virus, Aino virus and Chuzan virus against Schmallenberg virus infection
title_short Evaluating the protective efficacy of a trivalent vaccine containing Akabane virus, Aino virus and Chuzan virus against Schmallenberg virus infection
title_sort evaluating the protective efficacy of a trivalent vaccine containing akabane virus, aino virus and chuzan virus against schmallenberg virus infection
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4028744/
https://www.ncbi.nlm.nih.gov/pubmed/24313924
http://dx.doi.org/10.1186/1297-9716-44-114
work_keys_str_mv AT hechingersilke evaluatingtheprotectiveefficacyofatrivalentvaccinecontainingakabanevirusainovirusandchuzanvirusagainstschmallenbergvirusinfection
AT wernikekerstin evaluatingtheprotectiveefficacyofatrivalentvaccinecontainingakabanevirusainovirusandchuzanvirusagainstschmallenbergvirusinfection
AT beermartin evaluatingtheprotectiveefficacyofatrivalentvaccinecontainingakabanevirusainovirusandchuzanvirusagainstschmallenbergvirusinfection